TAM
AGN

Telluride Asset Management’s Allergan plc AGN Stock Holding History

Telluride Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,269
Closed -$261K – 358
2014
Q1 		$261K Buy
+1,269
New +$251K 0.22% 148

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM

Telluride Asset Management's AGN Position: Q2 2014 in Review

Telluride Asset Management sold out of Allergan plc (AGN) in Q2 2014, closing a stake of 1,269 shares — an estimated $261K sold.

Telluride Asset Management first reported a position in AGN in Q1 2014 and held it in 1 quarter. The position peaked at $261K in Q1 2014. 674 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

  • Telluride Asset Management reported no remaining Allergan plc position as of Q2 2014 after selling out during the quarter.
  • Telluride Asset Management sold 1,269 Allergan plc shares in Q2 2014, an estimated $261K.
  • Telluride Asset Management first reported a position in Allergan plc in Q1 2014 and held it in 1 quarter.
  • Telluride Asset Management's Allergan plc position peaked at $261K in Q1 2014.
  • 674 funds tracked by Wall St. Rank held Allergan plc as of Q2 2014.

Based on Telluride Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.